Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Cetuximab × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 71 Squamous Cell Carcinoma of Head and Neck 52 Carcinoma, Non-Small-Cell Lung 23 Head and Neck Neoplasms 22 Colonic Neoplasms 20 Neoplasm Metastasis 14 Neoplasms 13 Rectal Neoplasms 12 Lung Neoplasms 9 Pancreatic Neoplasms 8 Mouth Neoplasms 7 Laryngeal Neoplasms 6 Hypopharyngeal Neoplasms 6 Carcinoma 6 Solid Tumors 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Oropharyngeal Neoplasms 5 Breast Neoplasms 5 Ovarian Neoplasms 4 Gastrointestinal Neoplasms 4 Endometrial Neoplasms 4 Tongue Neoplasms 3 Recurrence 3 Melanoma 3 Colorectal Cancer Metastatic 3 Carcinoma, Squamous Cell 3 Carcinoma, Renal Cell 3 Carcinoma, Pancreatic Ductal 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡